Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis
- PMID: 30454669
- DOI: 10.1016/j.amepre.2018.08.007
Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis
Abstract
An RCT designed to increase Medicaid smokers' quitting success was conducted in California during 2012-2013. In the trial, alternative cessation treatment strategies were embedded in the state's ongoing quitline services. It found that modest financial incentives of up to $60 per participant and sending nicotine patches induced significantly higher cessation rates compared with usual care alone and usual care plus nicotine patches. Building upon that study, this study assessed potential population-level costs and benefits of integrating financial incentives and nicotine patches in a quitline setting for Medicaid smokers. A cost-benefit analysis was undertaken from the Medicaid program's perspective. The Cardiovascular Disease Policy Model was used to simulate future healthcare expenditures over a 10-year horizon for each treatment strategy for a study cohort of California Medicaid enrollees who were aged 35-64 years in 2014 (n=2,452,000). To simulate potential population-level benefits under each treatment strategy, each treatment was applied to all active smokers in the study cohort (n=478,300). Sensitivity analyses were conducted by varying key parameters, such as cessation costs, discount rate, relapse rates, and time horizon. Adding both financial incentives and nicotine patches to usual quitline care would result in $15 million net savings over 10 years, with a benefit-cost ratio of 1.30 compared with the usual care plus nicotine patches strategy. It would yield $44 million net savings, with a benefit-cost ratio of 1.90 compared with usual care alone. The strategy of providing financial incentives and mailing nicotine patches directly to Medicaid smokers who call the quitline is cost saving. SUPPLEMENT INFORMATION: This article is part of a supplement entitled Advancing Smoking Cessation in California's Medicaid Population, which is sponsored by the California Department of Public Health.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Incentives and Patches for Medicaid Smokers: An RCT.Am J Prev Med. 2018 Dec;55(6 Suppl 2):S138-S147. doi: 10.1016/j.amepre.2018.07.015. Am J Prev Med. 2018. PMID: 30454668 Clinical Trial.
-
Effects of Offering Nicotine Patches, Incentives, or Both on Quitline Demand.Am J Prev Med. 2018 Dec;55(6 Suppl 2):S170-S177. doi: 10.1016/j.amepre.2018.07.007. Am J Prev Med. 2018. PMID: 30454671
-
Direct-to-Member Household or Targeted Mailings: Incentivizing Medicaid Calls for Quitline Services.Am J Prev Med. 2018 Dec;55(6 Suppl 2):S178-S185. doi: 10.1016/j.amepre.2018.06.026. Am J Prev Med. 2018. PMID: 30454672
-
Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.Cancer. 2016 Apr 15;122(8):1150-9. doi: 10.1002/cncr.29926. Epub 2016 Feb 24. Cancer. 2016. PMID: 26916412 Free PMC article. Review.
-
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.Cancer Prev Res (Phila). 2020 Mar;13(3):261-272. doi: 10.1158/1940-6207.CAPR-19-0259. Cancer Prev Res (Phila). 2020. PMID: 32132120 Free PMC article. Review.
Cited by
-
Tobacco Treatment Disparities Among California Medicaid Members With and Without Chronic Disease Who Smoke.AJPM Focus. 2024 Nov 12;4(1):100292. doi: 10.1016/j.focus.2024.100292. eCollection 2025 Feb. AJPM Focus. 2024. PMID: 39866159 Free PMC article.
-
Aniqsaaq (To Breathe): Study protocol to develop and evaluate an Alaska Native family-based financial incentive intervention for smoking cessation.Contemp Clin Trials Commun. 2023 Apr 3;33:101129. doi: 10.1016/j.conctc.2023.101129. eCollection 2023 Jun. Contemp Clin Trials Commun. 2023. PMID: 37091507 Free PMC article.
-
Cost Effectiveness of the Tips From Former Smokers® Campaign-U.S., 2012-2018.Am J Prev Med. 2021 Mar;60(3):406-410. doi: 10.1016/j.amepre.2020.10.009. Epub 2021 Jan 14. Am J Prev Med. 2021. PMID: 33455819 Free PMC article.
-
Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives.Addiction. 2020 Mar;115(3):534-545. doi: 10.1111/add.14861. Epub 2019 Dec 17. Addiction. 2020. PMID: 31849138 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous